View Author
kidney uptake peptide analogue radiolabelled j nucl med somatostatin receptor study imaging radioactivity radiolabelled somatostatin analogues therapy tumour patient retention ep krenning radionuclide radiation animal gelofusine megalin effect 111 in-dtpa-octreotide chapter krenning radiolabelled peptides figure in-dtpa-octreotide lu-dota tumours cancer reduction group result tubules damage r valkema spect injection bf bernard function activity m melis wa breeman octreotide reabsorption protein pp kooij lysine treatment wh bakker control tumor bernard radiopeptide mtc-dmsa protection 99 mtc-mag 3 mechanism 99 mtc-dmsa vivo autoradiography administration amifostine 24 h p.i somatostatin analogues valkema visser toxicity biodistribution section neuroendocrine kidney protection 177 lu breeman netherland radiation dose rolleman cortex tissue
10 Most Recent Publications
|
Comparison of the binding and internalization properties of 12 DOTA-coupled and
111In-labelled CCK2/gastrin receptor binding peptides: A collaborative project under COST Action BM0607
(Article)
Aloj, L. Aurilio, M. Sosabowski, J.K. Breeman, W.A.P. Blois, E. de Koelewijn, S. Melis, M.L. Waser, B. Beetschen, K. Reubi, J.C. Jong, M. de Rinaldi, V. D'ambrosio, L. Tesauro, D. Peitl, P.K. Maina, T. Mansi, R. Guggenberg, E. von Joosten, L. |
2011-08-01
|
|
Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
(Article)
Vegt, E. Melis, M.L. Eek, A. Visser, M. de Brom, M. Oyen, W.J. Gotthardt, M. Jong, M. de Boerman, O.C. |
2011-04-01
|
|
Effect of interferon-a treatment on [68Ga-DOTA,Tyr3,Thre8] octreotide uptake in CA20948 tumors: A small-animal PET study
(Article)
Hanin, F.-X. Pauwels, S. Bol, A. Melis, M.L. Breeman, W.A.P. Jong, M. de Jamar, F. |
2011-04-01
|
|
Radiopeptides for Targeted Tumour Therapy and the Kidney
(Doctoral Thesis)
Melis, M.L. |
2010-12-16
|
|
Dynamic and static small-animal SPECT in rats for monitoring renal function after177Lu-labeled Tyr3-octreotate radionuclide therapy
(Article)
Melis, M.L. Swart, J. de Visser, M. de Berndsen, S.C. Koelewijn, S. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de |
2010-12-01
|
|
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues
(Article)
Schroeder, R.P.J. Müller, C. Reneman, S. Melis, M.L. Breeman, W.A.P. Blois, E. de Bangma, C.H. Krenning, E.P. Weerden, W.M. van Jong, M. de |
2010-07-01
|
|
Renal toxicity of radiolabeled peptides and antibody fragments: Mechanisms, impact on radionuclide therapy, and strategies for prevention
(Article)
Vegt, E. Jong, M. de Wetzels, J.F.M. Masereeuw, R. Melis, M.L. Oyen, W.J. Gotthardt, M. Boerman, O.C. |
2010-07-01
|
|
Androgen-regulated gastrin-releasing peptide receptor expression in androgen-dependent human prostate tumor xenografts
(Article)
Schroeder, R.P.J. Visser, M. de Weerden, W.M. van Ridder, C.M.A. Reneman, S. Melis, M.L. Breeman, W.A.P. Krenning, E.P. Jong, M. de |
2010-06-15
|
|
Nephrotoxicity in mice after repeated imaging using 111In- labeled peptides
(Article)
Melis, M.L. Vegt, E. Konijnenberg, M.W. Visser, M. de Bijster, M. Vermeij, M. Krenning, E.P. Boerman, O.C. Jong, M. de |
2010-06-01
|
|
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
(Article)
Rolleman, E.J. Melis, M.L. Valkema, R. Boerman, O.C. Krenning, E.P. Jong, M. de |
2010-05-01
|